Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Herombopag for Prevention of T-DM1-Induced Thrombocytopenia in Breast Cancer
NCT07198672Not yet recruiting
- Start
- Oct 2025
- Primary completion
- Oct 2027
- Modality
- Small Molecules
01
Overview
Open-label, single-arm trial of hetrombopag in Thrombocytopenia. Primary endpoint: Incidence of thrombocytopenia (<100 × 10^9/L). Planned start Oct 2025; status: not yet recruiting.
02
Drugs
hetrombopag
03
Conditions
Thrombocytopenia
Beyond the preview
Go deeper on NCT07198672.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07198672.